I think a key factor is what kinds of injuries and medical conditions are included or excluded from the protocol. If the parameters aren’t exceedingly tight, 100 could take MUCH less than a year to enroll. But they do need to get through IRBs before enrollment can begin, but a hospital IRB that already worked with ReCell wouldn’t give it the same kind of thorough review as one that didn’t.
- Forums
- ASX - By Stock
- AVH
- Ann: Pivotal Soft Tissue Trial Receives US FDA IDE Approval
Ann: Pivotal Soft Tissue Trial Receives US FDA IDE Approval, page-7
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.78 |
Change
0.110(4.12%) |
Mkt cap ! $195.7M |
Open | High | Low | Value | Volume |
$2.77 | $2.82 | $2.74 | $999.8K | 359.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5419 | $2.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.79 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5419 | 2.760 |
2 | 15000 | 2.740 |
1 | 5000 | 2.730 |
1 | 2500 | 2.720 |
1 | 5000 | 2.710 |
Price($) | Vol. | No. |
---|---|---|
2.790 | 10000 | 1 |
2.800 | 5705 | 4 |
2.810 | 23225 | 4 |
2.840 | 419 | 1 |
2.850 | 1495 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |